Regeneron Pharmaceuticals (REGN)

Net Receivables

$6.57B

Quarterly · Period ending: · USD

REGN logo

REGN Net Receivables

Latest reported$6.57B
REGN Quarterly Net Receivables ($200.00K → $6.57B)
High-resolution chart · PNG

REGN net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
6,565,400,000
5,731,000,000
5,741,100,000
5,687,100,000
5,610,000,000
5,561,000,000
6,211,900,000
6,107,100,000
5,717,100,000
5,222,200,000
5,667,300,000
5,584,500,000
5,121,300,000
5,118,600,000
5,328,700,000
5,548,300,000
5,161,400,000
4,839,000,000
6,036,500,000
5,452,000,000
6,998,600,000
4,173,000,000
4,114,700,000
4,039,500,000
2,811,300,000
2,933,200,000
2,785,600,000
2,660,000,000
2,455,900,000
2,305,200,000
2,243,200,000
2,202,945,000
2,039,247,000
1,943,932,000
1,974,340,000
1,971,449,000
1,844,547,000
1,749,548,000
1,611,620,000
1,643,872,000
1,751,971,000
1,865,221,000
1,467,793,000
1,439,315,000
1,395,125,000
1,338,462,000
976,372,000
927,254,000
893,924,000
1,047,496,000
954,967,000
992,824,000
876,016,000
802,638,000
693,120,000
601,271,000
435,380,000
238,347,000
103,035,000
78,447,000
84,564,000
88,156,000
81,917,000
82,287,000
95,196,000
71,858,000
65,568,000
67,766,000
60,046,000
48,209,000
35,212,000
37,744,000
32,838,000
32,960,000
18,320,000
10,968,000
20,478,000
33,632,000
7,493,000
7,940,000
12,141,000
11,010,000
36,521,000
10,536,000
16,830,000
10,371,000
43,102,000
24,866,000
25,397,000
59,882,000
15,529,000
9,197,000
7,871,000
7,238,000
4,017,000
4,521,000
2,986,000
2,739,000
2,975,000
3,547,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.